Profil
Antoine Béret is the founder of Trophos SA, which was founded in 1998.
He held the title of President & Head-Commercial Development from 2009 to 2012.
Dr. Béret is also the founder of Immunotech.
In addition to his founding positions, Dr. Béret held former positions as Chief Executive Officer at Genoscience Pharma, Chairman at Axenis SAS, Independent Director at Transgene SA, and Business Director at Crédit National SA.
Anciens postes connus de Antoine Béret
| Sociétés | Poste | Fin |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Chief Executive Officer | 10/11/2009 |
| Crédit National SA | Corporate Officer/Principal | - |
Immunotech
 Immunotech BiotechnologyHealth Technology Immunotech develops immunoassays and monoclonal antibodies. The company is headquartered in Marseille, France. | Founder | - |
Axenis SAS
 Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Chairman | - |
Genoscience Pharma
 Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Crédit National SA | Finance |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Immunotech
Immunotech BiotechnologyHealth Technology Immunotech develops immunoassays and monoclonal antibodies. The company is headquartered in Marseille, France. | Health Technology |
Genoscience Pharma
Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Health Technology |
Axenis SAS
Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Health Technology |
